Article Details

Seres Therapeutics Inc (NASDAQ:MCRB) Given Consensus Recommendation of “Buy” by Analysts

Retrieved on: 2019-12-28 13:15:00

Tags for this article:

Click the tags to see associated articles and topics

Seres Therapeutics Inc (NASDAQ:MCRB) Given Consensus Recommendation of “Buy” by Analysts. View article details on hiswai:

Excerpt

<div>Finally, <b>Vanguard Group</b> Inc. lifted its holdings in Seres Therapeutics by 128.7% in the second quarter. <b>Vanguard Group</b> Inc. now owns 2,060,327 ...</div>

Article found on:

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up